Research - Miami, Florida, United States
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. We are a platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies. We work on rare vascular diseases as well as more common indications effecting large patient populations.
DoubleClick
Outlook
Panopto
Varnish
Google Tag Manager
Mobile Friendly